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Key questions
What is already known about this subject?
 ► Patients with bicuspid aortic valve (BAV) present 
with different degrees of aortic dilation. Despite 
known phenotypic variations in BAV aortopathy, and 
differences in aortic architecture in BAV patients 
with concomitant aortic coarctation (CoA), determi-
nants of aortic growth rate are not fully known.
What does this study add?
 ► This study highlights differences in BAV patients 
with/without CoA based on cardiovascular magnetic 
resonance imaging data, identifying particularly dif-
ferences in root dilation. The study also reinforces 
previous echocardiographic observations on the as-
sociation between BAV morphotype and differences 
in aortic dilation, using a different imaging modality.
How might this impact on clinical practice?
 ► This study suggests that CoA patients with concom-
itant BAV disease could be treated as a separate 
group with a different phenotype, thus refining risk 
stratification and monitoring of potential progression 
of BAV aortopathy.
AbstrAct
Objectives This study aimed to identify determinants of 
aortic growth rate in bicuspid aortic valve (BAV) patients. 
We hypothesised that (1) BAV patients with repaired 
coarctation (CoA) exhibit decreased aortic growth rate, 
(2) moderate/severe re- coarctation (reCoA) results in 
increased growth rate, (3) patients with right non- coronary 
(RN) valve cusps fusion pattern exhibit increased aortic 
growth rate compared with right- left cusps fusion and type 
0 valves.
Methods Starting from n=521 BAV patients with 
cardiovascular magnetic resonance data, we identified 
n=145 patients with at least two scans for aortic growth 
analysis. Indexed areas of the sinuses of Valsalva and 
ascending aorta (AAo) were calculated from cine images 
in end- systole and end- diastole. Patients were classified 
based on dilation phenotype, presence of CoA, aortic valve 
function and BAV morphotype. Comparisons between 
groups were performed. Linear regression was carried out 
to identify associations between risk factors and aortic 
growth rate.
Results Patients (39±16 years of age, 68% male) had 
scans 3.7±1.8 years apart; 32 presented with AAo dilation, 
18 with aortic root dilation and 32 were overall dilated. 
Patients with repaired CoA (n=61) showed decreased 
aortic root growth rate compared with patients without 
CoA (p≤0.03) regardless of sex or age. ReCoA, aortic 
stenosis, regurgitation and history of hypertension were 
not associated with growth rate. RN fusion pattern showed 
the highest aortic root growth rate and type 0 the smallest 
(0.30 vs 0.08 cm2/m*year, end- systole, p=0.03).
Conclusions Presence of CoA and cusp fusion 
morphotype were associated with changes in rate of root 
dilation in our BAV population.
IntROduCtIOn
Bicuspid aortic valve (BAV) is a highly heter-
ogeneous congenital heart disease (CHD), 
commonly associated with increased risk 
of developing thoracic aortic aneurysms 
and acute aortic dissection,1 the latter 
increasing after aortic valve replacement 
(AVR).2 BAV aortopathy can range from 
slow- asymptomatic aortic diameter growth 
to rapid progression or early- life threatening 
aortic complications.3 In vitro and in vivo 
studies have explored the inherent defect of 
aortas in BAV patients leading to altered wall 
mechanical properties which contribute to 
aneurysm formation.4 5 However, at present 
there is no established risk marker to help in 
the prognosis of BAV aortic growth.6 Known 
predictors of BAV aortopathy progression 
include older age, male sex, increased systolic 
blood pressure, valvular dysfunction and BAV 
morphology.7 8 While no consistent correla-
tion has been reported between BAV morpho-
type and aortopathy pattern,9 the phenotype 
of dilation is reported to be predictive of the 
disease course, and thus being used to facili-
tate risk stratification and standardise surgical 
approaches.10 11
BAV is often concomitant with aortic coarc-
tation (CoA)12 and aortic wall complications 
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Figure 1 Patient selection. Inclusion criteria: two CMR 
scans prior to AVR (n = 182). Exclusion criteria: suboptimal 
quality of CMR cine images (n=7), unconfirmed bicuspid 
morphology (n=6), degenerative aortic valve, any 
concomitant either complex or moderate CHDs, including 
Shone’s complex (n=2), tetralogy of Fallot (n=2) and Epstein’s 
anomaly (n=1); connective tissue disorders, including Marfan 
(n=1), Turner (n=10) and Ehlers Danlos (n=1) syndromes; 
pseudo- CoA (n=1), Kawasaki disease (n=1), unrepaired 
CoA (n=6) and surgeries (n=2) such as aortic valvotomy and 
aortic arch reconstruction. AVR, aortic valve replacement; 
BAV, bicuspid aortic valve; CMR, cardiovascular magnetic 
resonance; CHD, congenital heart disease.
are frequent in adults with CoA,13 whereas those with 
progressive course of the disease may also develop aortic 
dilation and be at risk of aneurysm and aortic dissection. 
Recent studies have shown that ascending and post- CoA 
aortic diameters or dilations are linked to the degree of 
CoA severity14 and that, in a CoA population, patients 
with BAV were more likely to have moderate or severe 
ascending aorta (AAo) dilation compared with those 
with a trileaflet valve.15 While BAV- aortopathy is likely 
a reflection of BAV morphotype rather than CoA or its 
physiological effects,16 questions remain about changes 
in aortic growth in BAV+CoA patients compared with 
isolated BAV. Furthermore, the coexistence of CoA with 
BAV has been associated with increased risk of aortic 
dissection compared with patients with isolated CoA,17 
but does aortic growth rate vary compared with patients 
with isolated BAV?
Taking advantage of a large cohort of BAV patients with 
and without CoA, this study aims to assess the effect of 
CoA and other potential determinants on aortic growth 
rate. Based on a recent study from our group reporting 
morphological differences in the aortic arch architec-
ture in BAV patients with/without CoA,18 the primary 
hypothesis is that BAV+CoA patients exhibit slower aortic 
growth rate, while patients with re- coarctation (reCoA) 
exhibit increased aortic growth rate. Furthermore, based 
on differences in aortic growth across BAV fusion types 
established with echocardiography,19 a secondary hypoth-
esis is that patients with right non- coronary (RN) valve 
fusion type exhibit increased aortic growth rate.
MetHOds
Patient population
This was a longitudinal single- centre retrospective study. 
Consecutive BAV patients (n = 521) were identified in the 
cardiovascular magnetic resonance (CMR) imaging data-
base between 2009 and 2017, of which 182 patients had 
CMR scans at two or more time- points before AVR. When 
patients had more than two scans available, the least 
and the most recent were considered. Exclusion criteria 
included: suboptimal image quality (n=7), unconfirmed 
bicuspid morphology (n=6, even after consulting trans- 
thoracic/trans- oesophageal echocardiography or CT 
angiography when in doubt), degenerative aortic valve 
(n=1), concomitant either moderate or complex CHD 
(n=2 Shone’s complex, n=2 Tetralogy of Fallot and n=1 
Epstein’s anomaly), connective tissue disorders (n=1 
Marfan, n=10 Turner and n=1 Ehlers Danlos syndromes, 
confirmed by genetic results), other diseases (n=1 pseu-
do- CoA, n=1 Kawasaki disease), unrepaired CoA (n=6) 
and surgeries structurally affecting the aortic valve and/
or the aorta (n=1 aortic valvotomy and n=1 aortic arch 
reconstruction). A flowchart is provided in figure 1. 
All CMR data were acquired at 1.5 T (Avanto, Siemens 
Healthineers, Erlangen, Germany). Demographic and 
functional variables were collected from CMR reports, 
including age, height, sex, aortic valve morphology, 
severity of aortic regurgitation or stenosis, presence of 
repaired CoA, degree of reCoA and history of hyperten-
sion. The population was then divided into two subgroups, 
that is, patients with isolated BAV and patients with BAV 
and repaired CoA.
Aortic measurements
The aortic measurements were performed in the steady- 
state free precession cine images acquired in the three- 
chamber (3C) and left ventricular outflow tract (LVOT) 
views and in the oblique sagittal views, both at the level 
of the sinuses of Valsalva (SoV) and at the proximal AAo 
(figure 2). The axial views of the AAo were acquired using 
multiple planes resulting in true perpendicular planes, 
to consider possible dynamic changes over time and 
possible asymmetry of the aorta in keeping with the 2017 
European Society of Cardiology Guidelines on Valvular 
Heart Disease.20 The AAo measurement was taken at the 
level of the right pulmonary artery. Having verified intra- 
observer and inter- observer reproducibility on 20 random 
cases (intraclass correlation coefficient=0.988 and 0.967, 
respectively), all measurements were taken by a single 
operator, who received the anonymised cases in random 
sequence and was blinded as to the history of CoA. Aortic 
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Figure 2 CMR measurements. Cine images showing 
measurements of aortic diameters, (A) at 3C and (B) at 
left ventricular outflow tract view. The red lines show the 
diameters measured at the SoV level and the black lines at 
the proximal AAo. (C) Schematic representation of changes 
at end- diastole (green) and end- systole (blue) over time to 
capture the possible dynamic nature of dimensional changes. 
AAo, ascending aorta; SoV, sinuses of Valsalva.
Figure 3 Aortic dilation phenotypes and bicuspid aortic 
valve (BAV) morphotypes. (A) Classification of the aortic 
dilation configurations in our population showing aortic root 
dilation, ascending aorta dilation, aortic root and ascending 
aorta dilation, and no dilation. (B) Classification of the BAV 
morphotypes showing type 0 valve with no raphe, type 
1 valve with one central raphe having in one case a right 
coronary and left coronary fusion pattern and in the other 
case a right non- coronary fusion pattern, and type 2 valve 
with two raphes.
growth rate was defined as the difference in indexed 
aortic area over the two time- points, having normalised 
aortic area by height21:
 Growth Rate =
A2
H − A1H
t2−t1  
where A, area; H, height; t, time. In order to avoid the 
assumption of circularity, the aortic radius was derived as 
the average of the diameters at 3C and LVOT and thus 
area calculated as:
 A = pi
(D(3C)
2 ∗
D
(
LVOT
)
2
)
 
where D, diameter.
Variables and classification
Valve morphotype was classified as ‘type 0’ (ie, true BAV 
with no raphe), ‘type 1’ (ie, one central raphe) and ‘type 
2’ (ie, two central raphes). Furthermore, type 1 valves 
were subdivided intro right coronary and left coronary 
(RL) fusion patter, right coronary and RN fusion pattern 
and left coronary and left non- coronary (LN) fusion 
pattern.9 ReCoA was defined as a recurrence of narrowing 
at the CoA site. The severity of reCoA was assessed from 
the ratio of the isthmus diameter to the descending 
thoracic aorta, and classified as severe if <0.55, moderate 
to mild if 0.55–0.85 and absent if >0.85. The severity of 
aortic stenosis and aortic regurgitation were extracted 
from CMR reports and, for the purposes of this analysis, 
patients were classified as either having none- to- mild or 
moderate- to- severe stenosis/regurgitation. In addition, 
according to a modified Fazel classification of aortic 
dilation configurations10 22 patients were classified as 
presenting (1) increased SoV diameter, (2) increased 
AAo diameter, (3) increased SoV and AAo diameters, 
and (4) no substantial aortic growth, as summarised in 
figure 3. We classified patients as ‘no growth’ when aortic 
growth rate was <0.08 cm2/m*year, corresponding to a 
diameter change of <1.5 mm (ie, pixel spacing).
statistical analysis
Continuous variables are presented as mean±SD and 
categorical variables as counts or proportions. Normality 
was assessed with Shapiro test. Continuous variables were 
compared with a Mann- Whitney test, or with Kruskal- 
Wallis test and Dunn’s test for post hoc adjustment when 
comparing more than two groups (eg, valve morpho-
types). Categorical variables were compared with χ2 test. 
The association between demographic/clinical variables 
and aortic growth rate was assessed using linear regres-
sion, and only those variables showing a significant associ-
ation on a univariate model were further tested in a multi-
variate regression model. A p value <0.05 was considered 
an indicator of statistical significance, except for multiple 
comparisons where Bonferroni correction was applied. 
The analysis was carried out in R (R Foundation for Statis-
tical Computing, Vienna, Austria).
Results
A population n=145 BAV patients with two CMR scans 
was identified (age 39±16 years, 68% male). For each 
patient, the time interval between CMR scans was 3.7±1.8 
Protected by copyright.
 o
n
 D
ecem
ber 11, 2019 at University of Bristol Library.
http://openheart.bmj.com/
O
pen Heart: first published as 10.1136/openhrt-2019-001095 on 2 Novem
ber 2019. Downloaded from
 
Open Heart
4 Sophocleous F, et al. Open Heart 2019;6:e001095. doi:10.1136/openhrt-2019-001095
Table 1 Patient characteristics
Demographic and clinical 
variables Repaired CoA, n=61 NoCoA, n=84 P value
Time gap between CMR scans 4.6±1.5 (range: 1.3–7.7) 3.0±1.9 (range: 0.3–7.7) <0.001***
Mean age at baseline 34±13 (range: 13–60) 42±17 (range: 15–73) 0.006**
Mean age at last follow- up 38±13 (range: 18–64) 45±17 (range: 17–77) 0.02*
Males n=36, 59% n=62, 74% 0.06
ReCoA n=33, 54% – N/A
Moderate/severe reCoA n=12, 36% – N/A
Valve type 0 n=4, 7% n=11, 13% 0.01*
Valve type 1, RL fusion n=51, 84% n=52, 62%
Valve type 1, RN fusion n=3, 5% n=15, 18%
Moderate/severe aortic stenosis n=3, 5% n=26, 31% <0.001***
Moderate/severe aortic regurgitation n=4, 7% n=19, 22% 0.009**
Hypertensive patients n=26, 43% (22 under medication, 
three no medication and one 
unknown)
n=32, 38% (30 are under 
medication and two unknowns)
0.5
Type of CoA repair  ► End- to- end (n=33)
 ► Subclavian flap (n=9)
 ► Patch (n=7)
 ► Stent (n=3)
 ► Interposition graft (n=2)
  N/A
CMR, cardiovascular magnetic resonance; CoA, coarctation; reCoA, re- coarctation; RL, right coronary and left coronary; RN, right non- 
coronary.
Table 2 Distribution of patients according to aortic dilation phenotype and BAV morphotype
End- systole No dilation AAo dilation Root dilation Overall dilated
CoA Type 0 3 0 0 1
Type 1, RL 30 11 4 6
Type 1, RN 1 0 2 0
Type 1, LN 2 1 0 0
Type 2 0 0 0 0
No CoA Type 0 5 4 1 1
Type 1, RL 15 14 8 15
Type 1, RN 4 2 3 6
Type 1, LN 0 0 0 2
Type 2 3 0 0 1
Total 63 32 18 32
CoA, coarctation; LN, left non- coronary; RL, right coronary and left coronary; RN, right non- coronary.
years (range 0.3–7.7). Also, at baseline BAV+CoA patients 
were significantly younger age (34±13 vs 42±17, p=0.006). 
Patients’ characteristics are reported in table 1.
The most common BAV morphotype was the type 
1 (83%), predominantly with RL fusion type (71%). 
Overall, patients presented with varying degrees of aortic 
stenosis (none: n=87, mild: n=29, moderate: n=20, severe: 
n=9) and aortic regurgitation (none: n=72, mild: n=50, 
moderate: n=14, severe: n=9), and patients with isolated 
BAV presented more frequently with severe stenosis 
and/or regurgitation (table 1). There was no difference 
in history of hypertension between isolated BAV and 
BAV+CoA patients.
Overall, we classified 63 BAV patients without aortic 
dilation, 32 with AAo dilation, 18 with aortic root dila-
tion and 32 with overall dilated aorta, table 2. In the CoA 
subgroup, 54% patients had reCoA, of which 36% were 
moderate- to- severe.
Aortic growth rate in SoV was significantly lower in 
BAV+CoA patients compared with isolated BAV (end- 
diastole: 0.05±0.09 vs 0.13±0.2 cm2/m*year, p=0.03; end- 
systole: 0.05±0.09 vs 0.19±0.3 cm2/m*year, p=0.005). 
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Table 3 Results of univariate linear regression analysis assessing the association of demographic/clinical variables and aortic 
growth rate
Demographic and clinical variables
End- systole End- diastole
SoV AAo SoV AAo
Age at baseline p=0.7 p=0.7 p=0.9 p=0.6
Age at last follow- up p=1 p=0.5 p=0.8 p=0.4
Sex p=0.5 p=0.1 p=0.8 p=0.4
Presence of CoA p=0.004** p=0.1 p=0.01* p=0.05
ReCoA p=0.8 p=0.9 p=0.5 p=0.7
Severity of reCoA p=0.9 p=0.8 p=0.5 p=0.4
Valve morphotype p=0.008** p=0.07 p=0.01* p=0.07
Severity of aortic stenosis p=0.8 p=0.6 p=0.8 p=1
Severity of aortic regurgitation p=0.4 p=0.5 p=0.3 p=0.7
History of hypertension p=0.6 p=0.3 p=0.5 p=0.4
AAo, ascending aorta; CoA, coarctation; reCoA, re- coarctation; SoV, sinus of Valsalva.
Aortic growth rate in SoV at end- systole also varied 
significantly according to BAV morphotype, with RN 
fusion pattern showing the highest growth and type 
0 the smallest (0.3±0.5 vs 0.1±0.2 vs 0.08±0.1 cm2/m*-
year, p=0.03). An in- between groups analysis showed a 
significant difference between type 1 RL and RN valves 
(p=0.006) and between type 0 valves and type 1 RN valves 
(p=0.01). No correlation observed between aortic growth 
rate, age and sex (table 3).
Results from regression analysis are reported in table 3. 
ReCoA, severity of aortic stenosis and regurgitation, and 
history of hypertension were not associated with aortic 
growth rate, neither in the overall population nor in 
the BAV+CoA subgroup. In patients with CoA, type of 
surgical repair and age of repair did not correlate with 
aortic growth rate (p≥0.16 and p≥0.33, respectively) over 
this time window.
Multiple regression analysis showed that the concom-
itant absence of CoA with type 1 valve with RN fusion 
pattern in end- systole results in a 0.3 cm2/m*year 
increase in aortic root growth rate. From a clinical stand-
point, changes in aortic diameter guide the decision to 
intervene, and this corresponds to 1 mm/year increase in 
aortic diameter, compared with 0.5 mm/year for type 1 
valve with RL fusion pattern and 0.3 mm/year for type 0 
valve.
All diameters, area values and aortic growth rate as 
indexed area of AAo and SoV both in end- systole and 
end- diastole, corresponding to the subgroups of CoA, 
NoCoA, reCoA, vale type 0, type 1 with RL cusp fusion 
and RN cusp fusion are reported in the (online supple-
mentary material).
dIsCussIOn
This longitudinal study uses CMR data to explore changes 
in aortic growth rate in a cohort of BAV patients. Results 
showed that patients with repaired CoA tended to have 
slower aortic root growth rate compared with patients 
with isolated BAV. Previous work from our group based 
on a statistical shape modelling framework18 revealed 
nuanced differences in arch morphology in BAV patients 
with/without CoA, suggesting detrimental functional 
implications for some aortic arch architectures, and with 
BAV+CoA patients generally presenting with smaller 
ascending and larger descending aortas compared with 
isolated BAV. This agrees with observations in the liter-
ature that prior CoA repair may protect BAV aorta from 
rapid dilation.8 With regards to functional implications, 
a recent echocardiographic study of 631 BAV patients 
with and without CoA found that BAV patients with CoA 
were associated with increased risk of AAo complications, 
smaller aortic root dimensions and less severe valvular 
dysfunction compared with isolated BAV patients over a 
similar time window to that of our study, but this study did 
not differentiate repaired and unrepaired CoA patients.23
Our observations on growth rate, translated into yearly 
increase in aortic diameter, indicate that an unfavourable 
combination of type 1 valve with RN fusion in patients 
without CoA can result in a substantial increment in 
diameter of 1 mm/year, compared with valve type 0 where 
the root diameter increase was found to be 0.3 mm/year. 
Although seemingly small, these dimensions can have 
clinical implications, over a relatively short time window 
of 10–15 years, indicating patients that potentially would 
require surgical intervention versus those in which the 
process of aortic dilation progresses at a slower rate. 
Similar values of aortic growth rate have been reported in 
the literature. AAo growth rate in BAV patients can range 
from 0.2 to 2.3 mm/year depending on patient character-
istics.24 25 According to a transthoracic echocardiogram 
(TTE) study performed on an isolated BAV population of 
133 adults, the mean growth rate was 0.3 mm/year at the 
sinuses and 0.6 mm/year at the level of the AAo, whereas 
RL valve fusion morphotype and AAo dilation phenotype 
where associated with slower aortic growth,19 in agree-
ment with our results.
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Our previous cross- sectional study focused exclusively 
on aortic morphology suggested that patients with reCoA 
tended to present increased aortic diameters compared 
with CoA patients with successful repair and no residual 
narrowing,18 yet current results did not reveal an associa-
tion between reCoA and aortic growth rate. This may be 
partly due to a relatively short time window, nevertheless 
significant increases in aortic size were observed in other 
patients over this time. Aortic stenosis and regurgitation, 
as well as history of hypertension, were also not associated 
with aortic growth rate. It has been previously reported in 
the literature that BAV is a significant predictor of AAo 
complications in patients with CoA irrespectively of high 
blood pressure, and aortic dilation and dissection in CoA 
patients are not only explained by hypertension and valve 
dysfunction.13 Although BAV and CoA have been charac-
terised as ‘two villainous cardiovascular lesions in cahoots’ 
with a similar pathophysiology that is part of a diffuse arte-
riopathy,26 yet the heterogeneity and abnormal haemo-
dynamics characterising BAV disease make it difficult to 
identify the key mechanisms that should be investigated 
through more studies in BAV with and without CoA.23 27
This study focused exclusively on patients with BAV. 
Aortic growth in BAV patients is considerably more 
prevalent and faster compared with tricuspid aortic 
valve patients. Current, joint guidelines of the American 
College of Cardiology/American Heart Association and 
collaborating societies recommend elective repair for 
patients with/without BAV when the aortic diameter 
reaches ≥55 mm, or at 50 mm for those with BAV and: 
uncontrolled hypertension, family history of dissection 
and rapid growth rate >5 mm/year. The last indication 
includes presence of severe valve dysfunction (either 
stenosis/regurgitation) and an aortic diameter >45 mm.28 
Therefore, given that growth rate drives surgical indi-
cation in BAV patients, refining the knowledge of its 
behaviour in association with CoA is warranted. Our 
study shows that the coexistence of these two entities 
does not necessarily imply a faster growth rate. As the 
matter of fact, the presence of CoA showed a slower 
growth rate despite associated risk factors such as history 
of hypertension.
Considering the indexed areas and the follow- up 
measurements from the current study, four patients in this 
population would be identified to be at risk of aortic dissec-
tion and requiring intervention, with area >10 cm2/m 
and 48–50 mm diameter.21 29 It should also be noted that 
our population is relatively young (average age 39 years 
overall) and while we cannot extrapolate information on 
growth rate beyond the time window that was studied, we 
cannot exclude further aortic dilation in these patients. 
This requires further analysis, not only by considering 
a wider timeframe, but potentially also making use of 
predictive modelling methodologies that may allow us to 
study aortic growth over time.
Finally, measurements were performed during both 
systole and diastole. While this may not reflect clinical 
practice, it beings to address the potentially dynamic 
nature of the problem, which should be addressed in the 
future in a separate study focusing on changes in aortic 
distensibility.
The study has the limitations of a retrospective design. 
Blood pressure data (actual cuff pressure at the time of 
CMR) and other risk factors (such as smoke and dyslipi-
daemia) were not available for all patients based on the 
available clinical data; however, history of hypertension 
was considered in the analysis. With regards to dimen-
sional assessment, admittedly CMR imaging offers a 
limited spatial resolution compared with echocardiog-
raphy and CT imaging, nevertheless our results agree 
with values of growth rate reported in the literature from 
echocardiographic studies.19 While TTE remains the tech-
nique of choice in the clinical follow- up of BAV patients, 
a comparison between TTE and CMR in measuring prox-
imal AAo diameters in BAV patients showed that TTE 
measurements may be inaccurate in the presence of root 
asymmetry and RN fusion pattern.30 CMR imaging is 
increasingly utilised in clinical follow- up and assessment 
of these patients, particularly when aortic morphology 
cannot be accurately assessed by TTE. Also, in the case of 
aortic dilatation or aneurysmal enlargement, a CMR scan 
is recommended to fully evaluate the thoracic aorta, in 
terms of further assessing the severity of dilation and the 
involvement of the AAo.17
This study highlights the importance of studying aortic 
growth in BAV patients with and without associated CoA, 
since BAV- aortopathy is likely a reflection of BAV morpho-
type rather than CoA or its physiological effects. In this 
light, CoA patients with concomitant BAV disease should 
be considered as a separate group having two different 
disease phenotypes and receiving different monitoring 
and treatment from isolated CoA patients. In addition, 
this study confirms that patients with isolated BAV and 
RN fusion pattern may present substantially faster aortic 
root growth, whereas the more common aortic dilation 
phenotype and valve fusion pattern appeared as a more 
stable disease entity with slower progression. Therefore, 
patient stratification and identification of risk factors of 
aortic growth can lead to a more targeted prognosis and 
monitoring of the condition.
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